Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

NCT01896232 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

683

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism
Chronic Kidney Disease

Interventions

DRUG: Etelcalcetide
DRUG: Cinacalcet
DRUG: Oral Placebo
DRUG: Intravenous Placebo

Sponsor

Amgen